Cvijic Christine Mikail's Form 4 filing
Neurogene Inc. (NGNE) · filed Mar 17, 2025
- Accession no.
- 0001404644-25-000007
- Filed
- Mar 17, 2025
- Trade date
- Mar 13, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $76.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cvijic Christine MikailCIK 0001543663 | Officer (President and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Common Stock | SSaleDisposed | −4,501 | $16.94 | −$76,246.94 | 72,343 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.